Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Oral Psilocybin by Revive Therapeutics for Substance (Drug) Abuse: Likelihood of Approval
Oral Psilocybin is under clinical development by Revive Therapeutics and currently in Phase II for Substance (Drug) Abuse. According to...